About Candel Therapeutics, Inc. 
Candel Therapeutics, Inc.
Miscellaneous
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 24 Schemes (26.48%)
Foreign Institutions
Held by 32 Foreign Institutions (1.08%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-9 Million
Miscellaneous
USD 353 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.39
-89.33%
6.80






